Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03938883 Completed - Refractive Surgery Clinical Trials

Ocular Bandage Gel (OBG) Pivotal Trial in Patients Undergoing Photorefractive Keratectomy ("PRK")

Start date: June 25, 2019
Phase: N/A
Study type: Interventional

Prospective, randomized, masked (reading center), controlled pivotal study of Ocular Bandage Gel (OBG) vs. a bandage contact lens (BCL) in subjects who have undergone bilateral photorefractive keratectomy (PRK).

NCT ID: NCT03938870 Completed - Dementia Clinical Trials

CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease

Start date: August 18, 2015
Phase:
Study type: Observational

Alzheimer's disease (AD) is the most common cause of dementia and currently has no disease modifying treatments or simple accurate diagnostic tests. The goal of this project is to study how tau (a protein thought to cause AD) is made, transported and cleared in the human body. Better understanding of these processes may lead to improved understanding of AD, earlier diagnosis and a way to evaluate treatment.

NCT ID: NCT03938467 Completed - Clinical trials for Rate of Positive Culture Growth for C.Acnes From Specimens Obtained From the Shoulders of Patients Undergoing Primary Shoulder Arthroplasty

Irrisept C.Acnes Study

Start date: March 1, 2021
Phase: Phase 4
Study type: Interventional

A Prospective, Randomized, Controlled Trial Comparing An Irrisept Antiseptic Irrigation With 0.05% Chlorhexidine Gluconate versus Standard of Care Prophylaxis Chlorohexidine Wipes

NCT ID: NCT03938246 Completed - Clinical trials for Non-Alcoholic Fatty Liver Disease

Study of TVB 2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Start date: March 22, 2019
Phase: Phase 2
Study type: Interventional

This is a Phase 2 multi-center, randomized, single-blind, placebo-controlled study to evaluate the safety and efficacy of TVB-2640 in subjects with non-alcoholic steatohepatitis (NASH), a type of fatty liver disease. Subjects will be randomly assigned to 1 of 2 treatment groups (TVB- 2640 at one of three doses or placebo). Following randomization, subjects will begin the 12-week treatment period and will receive once daily TVB-2640 or placebo.

NCT ID: NCT03937687 Completed - Clinical trials for Caffeine, Teacrine, and Dynamine: Effects on Performance

The Effects of a Combination of TeaCrine®, Dynamine, and Caffeine in Law Enforcement

Start date: May 4, 2019
Phase: Early Phase 1
Study type: Interventional

The purpose of this randomized, placebo-controlled, three-condition, double-blind, between-subjects clinical trial is to determine and compare the effects of the combination of TeaCrine®, Dynamine, and caffeine to a placebo and caffeine condition on reaction time and target acquisition and accuracy. A secondary purpose is to observe the changes in hemodynamic variables in response to this combination.

NCT ID: NCT03937375 Completed - Surgery Clinical Trials

Re-Evaluation of the Effects of High PEEP During General Anesthesia For Surgery (REPEAT)

REPEAT
Start date: January 1, 2019
Phase:
Study type: Observational

Aiming to understand the isolated impact of high PEEP in patients undergoing mechanical ventilation for general anesthesia for surgery, three appropriately sized international multicentre randomized controlled trials have been performed over recent years: the 'PROtective Ventilation using HIgh versus LOw PEEP trial (PROVHILO), the 'individualized PeRioperative Open-lung Ventilation trial' (iPROVE), and the 'Protective intraoperative ventilation with higher versus lower levels of positive end-expiratory pressure in obese patients trial' (PROBESE). These three trials had several similarities in key areas of their study protocols, inclusion and exclusion criteria, and collected data, and even the primary and secondary outcomes. Of note, the three trials combined high PEEP with recruitment manoeuvres. This allows an individual patient data meta-analysis.

NCT ID: NCT03937011 Completed - Clinical trials for Gynecology - Vaginal Cuff Closure

Post-Market Clinical Follow-Up of STRATAFIX™ Spiral PDS™ PLUS

Start date: December 13, 2019
Phase:
Study type: Observational

This single-arm, prospective, observational multicenter study will collect clinical data in a post-market setting across two different specialties in Robotic surgical procedures: Bariatric Sleeve gastrectomy (Staple line reinforcement) and Hysterectomy (Vaginal cuff closure). Investigators will perform the procedure using SFX Spiral PDS Plus in compliance with their standard surgical approach and the IFU.

NCT ID: NCT03936985 Completed - Opioid Abuse Clinical Trials

Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool

PHARMSCREEN
Start date: November 4, 2019
Phase:
Study type: Observational

The goal of the study is to validate a Prescription Drug Monitoring Program-based opioid risk metric to discriminate between low, moderate, and high-risk opioid use disorder. The World Health Organization Alcohol, Smoking, and Substance Involvement Screening Test (WHO ASSIST) will be used as the gold standard instrument that defines patient risk levels. No intervention or hypothesis will be tested.

NCT ID: NCT03936803 Completed - Clinical trials for Non-Alcoholic Fatty Liver Disease

Interval Training Versus Electro Acupuncture on Liver Functions in Patients With Non-alcoholic Fatty Liver Disease

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

in this study, the investigators compare the effect of interval training exercise and electroacupuncture on liver functions in non-alcoholic fatty liver disease patients

NCT ID: NCT03936738 Completed - Quality of Life Clinical Trials

Posttraumatic Stress Disorder and Quality of Life of Avalanche Survivors From 2014 to 2018, Based on the French North Alpine Avalanche Register

ESPTAvalanche
Start date: May 1, 2019
Phase:
Study type: Observational

The aim of this study is to identify if an avalanche accident has a psychological impact on avalanche victims. The investigators hypothesize that being exposed to an avalanche could generate enough stress to develop posttraumatic stress symptoms or even more, an authentic posttraumatic stress disorder (PTSD). Additionally, the investigators think that such symptoms might lead to physical and psychological distress in daily life. Lastly, the investigators suppose that a serious traumatism, a complete and/or prolonged burial, the death of a family member or a closed friend could be a potential risk factors to develop PTSD symptoms in avalanche victims. To evaluate post traumatic stress symptoms and the quality of life of avalanche survivors, the investigators use the Impact of Event Scale - Revised and the Short Form 12. These two scales are included in a standardized questionnaire, which is submitted to avalanche victims during a phone call.